{"entity":{"type":"insider","cik":"0001411984","url":"/insider/0001411984","json_url":"/insider/0001411984.json","name":"Van Plew Daniel P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":165,"n_filings":25,"first":"2010-12-20","last":"2024-02-16","span_basis":"filed_date"},"name_variants":[{"name":"Van Plew Daniel P","source":"filing","n_filings":25,"first_seen":"2010-12-20","last_seen":"2024-02-16"}],"transactions":[{"id":2715732,"accession":"0001968202-24-000066","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001968202-24-000066","line_url":"/filing/0001968202-24-000066","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10434.0,"shares_display":"10,434","price_per_share":942.2778397546483,"price_display":"942.28","price_state":"stated","total_value":9831726.98,"total_display":"9,831,726.98","total_whole":"9,831,727","shares_owned_after":25136.0,"shares_owned_after_display":"25,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-16","scope":"insider","n_lines":13},{"id":8308068,"accession":"0001968202-23-000028","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-23-000028","line_url":"/filing/0001968202-23-000028","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6197.0,"shares_display":"6,197","price_per_share":841.7093545263838,"price_display":"841.71","price_state":"stated","total_value":5216072.87,"total_display":"5,216,072.87","total_whole":"5,216,073","shares_owned_after":21508.0,"shares_owned_after_display":"21,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider","n_lines":10},{"id":6689721,"accession":"0001883850-22-000098","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001883850-22-000098","line_url":"/filing/0001883850-22-000098","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11972.0,"shares_display":"11,972","price_per_share":740.7501119278317,"price_display":"740.75","price_state":"stated","total_value":8868260.34,"total_display":"8,868,260.34","total_whole":"8,868,260","shares_owned_after":36418.0,"shares_owned_after_display":"36,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-25","scope":"insider","n_lines":14},{"id":6292747,"accession":"0001883850-22-000092","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001883850-22-000092","line_url":"/filing/0001883850-22-000092","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7886.0,"shares_display":"7,886","price_per_share":745.4048846056303,"price_display":"745.40","price_state":"stated","total_value":5878262.92,"total_display":"5,878,262.92","total_whole":"5,878,263","shares_owned_after":30982.0,"shares_owned_after_display":"30,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-08","scope":"insider","n_lines":6},{"id":6795258,"accession":"0001883850-22-000070","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1052.0,"shares_display":"1,052","price_per_share":716.28,"price_display":"716.28","price_state":"stated","total_value":753526.56,"total_display":"753,526.56","total_whole":"753,527","shares_owned_after":32253.0,"shares_owned_after_display":"32,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795252,"accession":"0001883850-22-000070","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":861.0,"shares_display":"861","price_per_share":715.39,"price_display":"715.39","price_state":"stated","total_value":615950.79,"total_display":"615,950.79","total_whole":"615,951","shares_owned_after":33305.0,"shares_owned_after_display":"33,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795248,"accession":"0001883850-22-000070","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647.0,"shares_display":"647","price_per_share":717.59,"price_display":"717.59","price_state":"stated","total_value":464280.73,"total_display":"464,280.73","total_whole":"464,281","shares_owned_after":31606.0,"shares_owned_after_display":"31,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795242,"accession":"0001883850-22-000070","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":572.0,"shares_display":"572","price_per_share":713.67,"price_display":"713.67","price_state":"stated","total_value":408219.24,"total_display":"408,219.24","total_whole":"408,219","shares_owned_after":34433.0,"shares_owned_after_display":"34,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795241,"accession":"0001883850-22-000070","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":718.5,"price_display":"718.50","price_state":"stated","total_value":312547.5,"total_display":"312,547.50","total_whole":"312,548","shares_owned_after":31171.0,"shares_owned_after_display":"31,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795237,"accession":"0001883850-22-000070","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":267.0,"shares_display":"267","price_per_share":714.42,"price_display":"714.42","price_state":"stated","total_value":190750.14,"total_display":"190,750.14","total_whole":"190,750","shares_owned_after":34166.0,"shares_owned_after_display":"34,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6795235,"accession":"0001883850-22-000070","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001883850-22-000070","line_url":"/filing/0001883850-22-000070#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001411984","owner_name":"Van Plew Daniel P","owner_display_name":"Van Plew Daniel P","owner_url":"/insider/0001411984","role":"Officer (EVP & General Mgr, Industrial)","role_mark":"O","role_mark_label":"Officer (EVP & General Mgr, Industrial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Mgr, Industrial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":181.0,"shares_display":"181","price_per_share":720.41,"price_display":"720.41","price_state":"stated","total_value":130394.21,"total_display":"130,394.21","total_whole":"130,394","shares_owned_after":30831.0,"shares_owned_after_display":"30,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"}],"collapsed":true,"next_cursor":"2022-09-12|6795235","ledger_fault":false,"count":{"value":165,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":165,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":165},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS, INC.","url":"/issuer/0000872589","role":"Officer (EVP & General Mgr, Industrial)","n_filings":25,"first_seen":"2010-12-20","last_seen":"2024-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001411984","retrieved_at":"2026-08-26T22:55:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}